Princeton sues drug companies, pharmacy intermediaries over ‘artificially inflating’ insulin prices
In June, Princeton sued major insulin manufacturers and pharmacy benefit managers, alleging they conspired to artificially inflate insulin prices and caused the University to overpay for employee healthcare costs.
In June, Princeton sued major insulin manufacturers and pharmacy benefit managers, alleging they conspired to artificially inflate insulin prices and caused the University to overpay for employee healthcare costs.